UBS Group’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.4K | Sell |
120,176
-134,568
| -53% | -$82.2K | ﹤0.01% | 6203 |
|
|
2025
Q1 | $145K | Sell |
254,744
-223,764
| -47% | -$128K | ﹤0.01% | 5514 |
|
|
2024
Q4 | $684K | Buy |
478,508
+452,370
| +1,731% | +$647K | ﹤0.01% | 4499 |
|
|
2024
Q3 | $50.4K | Buy |
26,138
+9,293
| +55% | +$17.9K | ﹤0.01% | 5616 |
|
|
2024
Q2 | $52.2K | Sell |
16,845
-93,331
| -85% | -$289K | ﹤0.01% | 5512 |
|
|
2024
Q1 | $576K | Buy |
110,176
+65,162
| +145% | +$341K | ﹤0.01% | 3996 |
|
|
2023
Q4 | $146K | Buy |
45,014
+19,530
| +77% | +$63.3K | ﹤0.01% | 4778 |
|
|
2023
Q3 | $65K | Sell |
25,484
-837
| -3% | -$2.13K | ﹤0.01% | 4999 |
|
|
2023
Q2 | $155K | Buy |
26,321
+11,592
| +79% | +$68K | ﹤0.01% | 4620 |
|
|
2023
Q1 | $42K | Buy |
14,729
+2,669
| +22% | +$7.61K | ﹤0.01% | 5493 |
|
|
2022
Q4 | $24.2K | Buy |
+12,060
| New | +$24.2K | ﹤0.01% | 6281 |
|
|
2022
Q3 | – | Sell |
-261
| Closed | -$1K | – | 9692 |
|
|
2022
Q2 | $1K | Sell |
261
-106
| -29% | -$406 | ﹤0.01% | 8921 |
|
|
2022
Q1 | $4K | Sell |
367
-2,923
| -89% | -$31.9K | ﹤0.01% | 8264 |
|
|
2021
Q4 | $62K | Buy |
3,290
+2,915
| +777% | +$54.9K | ﹤0.01% | 5637 |
|
|
2021
Q3 | $8K | Buy |
+375
| New | +$8K | ﹤0.01% | 7078 |
|